Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Skin grafts on mice can cause an immune response leading to hair loss, useful for studying human hair loss conditions.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Nivolumab can cause hair loss as a rare side effect.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Alopecia Areata might be linked to Crohn's disease.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

Certain gene variations may increase the risk and severity of alopecia areata.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.